Salmon Calcitonin is a peptide hormone analog derived from salmon calcitonin, much more potent than human calcitonin. It is FDA-approved for treating postmenopausal osteoporosis, Paget's disease, and hypercalcemia of malignancy.
In the literature, Salmon Calcitonin appears most often in work focused on bone health and inflammation. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Salmon Calcitonin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
Activin A is a homodimeric glycoprotein involved in embryonic development, stem cell regulation, inflammation, and bone metabolism. It is primarily studied as a therapeutic target due to its involvement in various disease processes like fibrosis and cachexia.
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
A blend of GHK-Cu, BPC-157, TB-500, and KPV studied for combined skin, gut, and tissue repair research.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.